TRU TruScreen Group Limited

—Mkt Cap: —P/E: —

TruScreen Group Limited, together with its subsidiaries, develops, manufacture, and sale of cancer detection devices and systems in Mexico, China, Central Asia, Vietnam, Zimbabwe, Indonesia, India, and the Middle East/No…

Key Statistics

Company
Market Cap—
Enterprise Value4.16M USD
Revenue (TTM)1.95M USD
Gross Profit530.61K USD
Net Income (TTM)-1.56M USD
Revenue/Share0.0040 AUD
Last Price—
Fiscal Year EndMar 2026
MR QuarterMar 2026
Employees—
CountryAU
SectorHealthcare
IndustryMedical Devices & Supplies
ISINNZTRUE0001S7
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue2.13
P/S2.97
P/B3.30
EPS (TTM)0.00
EPS (Forward)—
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin31.54%
Oper. Margin-48.14%
EBITDA Margin0.00%
Profit Margin-92.53%
ROE-87.13%
ROA-60.09%
Growth
Revenue Growth120.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.71M USD
CapEx (TTM)—
FCF Margin-55.95%
FCF Yield—
Net Debt-872.08K USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.08
Current Ratio3.29
Quick Ratio2.67
Book Value/Sh0.0024 AUD
Cash/Share0.0020 AUD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 AUD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)0.0240 AUD
Target Range0.0240 AUD – 0.0240 AUD
# Analysts1
Ownership
Shares Out.1.05B
Float609.52M
Insiders18.93%
Institutions2.09%
Technical
SMA 500.0111 AUD
SMA 2000.0136 AUD
Beta-0.06
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)370.65K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—